Neuromodulation and Yoga for mTBI and Chronic Pain
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04517604 |
|
Recruitment Status :
Recruiting
First Posted : August 18, 2020
Last Update Posted : August 2, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Mild Traumatic Brain Injury Chronic Pain | Device: Magventure MagProx100 with MagOption | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 20 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Intervention Model Description: | Intermittent Theta Burst Stimulation (iTBS) in combination with Love Your Brain Yoga Program. 6 weekly sessions of iTBS given prior to small group yoga. |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Feasibility of a Combined Neuromodulation and Yoga Intervention for Veterans With Mild Traumatic Brain Injury and Chronic Pain |
| Actual Study Start Date : | June 1, 2021 |
| Estimated Primary Completion Date : | November 30, 2022 |
| Estimated Study Completion Date : | November 30, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: iTBS+yoga
Participants will receive 6 sessions of intermittent theta burst stimulation (iTBS) and the LoveYourBrain Yoga program. The LoveYourBrain Yoga program was specifically designed for people with TBI.
|
Device: Magventure MagProx100 with MagOption
iTBS will be delivered utilizing the MagVentrure MagPro X100 with MagOption stimulator that includes active and placebo coils (C-B60 Butterfly coils). Only the active setting will be used.A MagVenture C-B60 coil will be used to deliver single pulse TMS to the non-dominant MC to identify the ab-ductor pollicis brevis (APB) muscle coordinates. The integrated Localite neuronavigation system will be used. |
- Session Completion Rate [ Time Frame: Endpoint - after last iTBS+yoga session, approximately 6 weeks ]For feasibility, we will track the number of iTBS+yoga sessions completed and compute completion percentage rates for each participant as a metric of feasibility.
- Semi-structured qualitative interviews of acceptability [ Time Frame: Endpoint - after last iTBS+yoga session, approximately 6 weeks ]Regarding acceptability, the semi-structured interviews will be audio-recorded, transcribed verbatim and analyzed by 2 qualitative experts using thematic coding and constant comparison techniques. Qualitative analysis software will be used to support analyses.
- Mayo-Portland Adaptability Index [ Time Frame: Baseline (Pre-iTBS+yoga treatment) and Endpoint (after last iTBS+yoga treatment, approximately 6 weeks) ]The Mayo-Portland Adaptability Index is a TBI Common Data Element assessment of function and participation. It includes 35 items each scored on a scale of 0 to 4, with 0 meaning no problems (better), and 4 meaning severe problems (worse). Minimum (best) score would be 0 and maximum (worst) score would be 140.
- Brief Pain Inventory [ Time Frame: Baseline (Pre-iTBS+yoga treatment) and Endpoint (after last iTBS+yoga treatment, approximately 6 weeks) ]The Brief Pain Inventory is a self-report measure of pain symptoms throughout the body. It has 6 main items and each item is scored on a scale of 0 to 10 with 0 meaning no pain (better), and 10 meaning pain as bad as you can imagine (worse). Minimum (best) score would be 0 and maximum (worst) score would be 50.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 22 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 22+ years of age
- Can read and speak English
- Perceive themselves as able to participate in gentle physical movements and cleared by study physician to do so.
- mTBI Criteria: Symptom Attribution and Classification (SACA) criteria for mTBI (without requirement of clinical neuropsychological impairment)
- Chronic pain: pain that persists for >6 months and is of moderate to severe intensity with a score of >5 on specific items on the Brief Pain Inventory (BPI)
Exclusion Criteria:
- Contraindications to iTBS/TMS (e.g. epilepsy, history of anoxic brain injury or heart disease)
- Contraindications to MRI (e.g., claustrophobia, ferromagnetic metal implants)
- History of moderate to severe TBI
- History of or current psychosis not due to an external cause (e.g., due to illicit drug use)
- Are pregnant or nursing
- Within 12 weeks of a major surgery/operation
- Have questionably valid test profiles
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04517604
| United States, Illinois | |
| Edward Hines Jr. VA Hospital, Hines, IL | Recruiting |
| Hines, Illinois, United States, 60141-5000 | |
| Contact: William Wolf, PhD 708-202-5689 William.Wolf@va.gov | |
| Contact: Amanda Smithy (708) 202-8387 ext 25691 Amanda.Smithy@va.gov | |
| Principal Investigator: Amy A Herrold, PhD BA | |
| Principal Investigator: | Amy A Herrold, PhD BA | Edward Hines Jr. VA Hospital, Hines, IL |
| Responsible Party: | VA Office of Research and Development |
| ClinicalTrials.gov Identifier: | NCT04517604 |
| Other Study ID Numbers: |
N3611-P I21RX003611 ( U.S. NIH Grant/Contract ) |
| First Posted: | August 18, 2020 Key Record Dates |
| Last Update Posted: | August 2, 2021 |
| Last Verified: | July 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | A de-identified data set will be created and shared.Final data sets will be made available as per Hines VA Hospital local policy for long term storage and access until enterprise-level resources become available. These data will be available upon request by researchers and scientists in accordance with federal guidelines and Hines local policy. The data provided will be sufficient for anyone to perform analogous or supplemental analyses that would permit validation of the analysis and results. The sharing of data will enable others to evaluate the data and to validate and interpret the data independently. In order to insure that replication is possible and transparency, statistical code complementary to datasets will be made available through the Federal Interagency Traumatic Brain Injury Research Informatics System. |
| Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Clinical Study Report (CSR) Analytic Code |
| Time Frame: | After primary publication of study data. |
| Access Criteria: | These data will be available upon request by researchers and scientists in accordance with federal guidelines and Hines local policy. |
| URL: | https://fitbir.nih.gov/ |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
| Product Manufactured in and Exported from the U.S.: | No |
|
traumatic brain injury concussion chronic pain pain |
neuromodulation transcranial magnetic stimulation intermittent theta burst stimulation yoga |
|
Brain Injuries Brain Injuries, Traumatic Brain Concussion Chronic Pain Wounds and Injuries Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Craniocerebral Trauma Trauma, Nervous System Pain Neurologic Manifestations Head Injuries, Closed Wounds, Nonpenetrating |

